Adam Bagg - Concepedia

Author

Adam Bagg

Also Known As

A Bagg, A. BAGG, A. Bagg, ADAM BAGG, Adam Bagg, Adam Bagg, MD, Elizabeth O. Hexner, Jacky, Peter B., Kaul, Karen L, Peter Nowell

341

Publications

21.8K

Citations

H-Index

104

Concepts

All Affiliations

University of Pennsylvania Hospital of the University of Pennsylvania Cornell University Massachusetts General Hospital The University of Texas MD Anderson Cancer Center

About

Adam Bagg is an author at University of Pennsylvania specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	52	7.9K
2	Health Sciences	11	11	833
3	Engineering	2	2	46
4	Natural Sciences	2	2	154
5	Public Health	2	2	62

Adam Bagg

121

Publications

20.2K

Citations

H-Index

Page 1

	Year	Citations
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia David L. Porter, Bruce L. Levine, Michael Kalos, New England Journal of Medicine Chimeric Antigen ReceptorChronic Lymphoid LeukemiaAutoimmune DiseaseLymphocyte DevelopmentImmunology	2011	3.5K
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Blood	2022	2.4K
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia Michael Kalos, Bruce L. Levine, David L. Porter, Science Translational Medicine	2011	2.4K
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia David Porter, Wei‐Ting Hwang, Noelle V. Frey, Science Translational Medicine	2015	1.7K
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer Steven E. Raper, Narendra Chirmule, Frank S. Lee, Molecular Genetics and Metabolism InflammationAutoimmune DiseaseDisease MechanismImmunodeficienciesImmunology	2003	1.5K
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus, Blood	2013	1.1K
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, New England Journal of Medicine Cell TherapyImmunologyPathologyAutologous TransplantationCd4 T Cell Responses	2015	614
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Blood	2017	590
Survival of acute myeloid leukemia cells requires PI3 kinase activation Qing Xu, Serge-Emile Simpson, Timothy J. Scialla, Blood	2003	471
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia Miriam Kim, Kyung–Rok Yu, Saad S. Kenderian, Cell Cell TherapyAcute Myeloid LeukemiaImmunologyHematologyAutoimmunity	2018	450

Page 1